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Abstract
This study aimed to evaluate the anti-inflammatory and antinociceptive effects of hydroalcoholic extract of 
P.gonoacantha leaves (EPG). The toxic effect of the EPG was tested against A.salina in order to determine a secure 
dose for subsequent assays. The antinociception was evaluated using the acetic acid-induced writhing and hot 
plate tests in Wistar rats. The anti-inflammatory effect of EPG was evaluated by carrageenan-induced paw edema 
tests in rats. The bioassay with A.salina showed low toxicity of EPG (LC50=1,508mg/L). Oral administration of 
EPG (50, 100 and 150mg/kg) significantly decreased the number of acetic acid-induced writhes, around 61.3%, 
71.8% and 64.9% respectively. However, EPG failed to prolong the latency time in the hot plate test, suggesting 
that EPG predominantly inhibits peripheral pain mechanisms. The oral administration of EPG at doses of 50 
and 100mg/kg significantly inhibited paw edema at 3rd h after the injection of the phlogistic agent by 34.5% and 
37.5%, respectively. These data suggest that EPG has both antinociceptive and anti-inflammatory activities, and 
these effects may be attributed to inhibition of COX-2 and prostaglandin release. 
Keywords: Analgesic, Herbal Medicines, Inflammation.
Resumo
Este estudo teve como objetivo avaliar os efeitos anti-inflamatórios e antinociceptivos do extrato das folhas de P. 
gonoacantha (EPG). O efeito tóxico de EPG foi testado contra A. salina, a fim de determinar a dosagem segura 
para os ensaios subsequentes. A antinocicepção em ratos Wistar foi avaliada utilizando o modelo de contorções 
abdominais induzidas por ácido acético e testes em placa aquecida. O efeito anti-inflamatório de EPG foi 
avaliada por testes de edema da pata induzido por carragenina em ratos. O bioensaio com A. salina mostrou uma 
baixa toxicidade do EPG (LC50 = 1,508 mg.L
-1). A administração oral de EPG (50, 100 e 150 mg.kg-1) reduziu 
significativamente o número de contorções induzidas por ácido acético, em torno de 61,3%, 71,8% e 64,9%, 
respectivamente. No entanto, o EPG não prolongou o tempo de latência no teste da placa quente, o que sugere que 
EPG iniba predominantemente os mecanismos de dor periférica. A administração oral de EPG, em doses de 50 e 
100mg.kg-1 inibiu significativamente o edema de pata após 3 h de administração do agente flogístico em 34,5% 
e 37,5%, respectivamente. Estes dados sugerem que a EPG possui atividade tanto antinociceptiva como anti-
inflamatória, podendo estes efeitos ser atribuídos à inibição da COX-2 e libertação de prostaglandinas.
Palavras-chave: Analgésico, plantas medicinais, inflamação
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1 Introduction
he inflammatory reaction, typically characterized 
by redness, swelling, heat, and pain, is one of the 
most common manifestations of many diseases 
afflicting millions of people worldwide (Rang et al., 
2011). The inflammation is the main of host defense 
mechanisms against invading pathogens. However, 
persistent or over inflammation leads to tissue damage 
and possibly failure of organs.
Numerous studies have been carried out to develop 
more powerful anti-inflammatory drugs with lesser side 
effects, and the interest researches on herbal medicines 
for producing drugs that are more efficient has been 
intensified in recent years (Rates, 2001; Castardo et al., 
2008). Approximately 48% of drugs used in therapy come 
directly or indirectly from natural products, especially 
medicinal plants (Balunas and Kinghorn, 2005). 
Piptadenia gonoacantha (Leguminosae - Mimosoide-
ae) is a common tree species native to Atlantic Forest in 
southern and southeastern Brazil. This species is easily 
identified by its bark with longitudinal wings filled 
with woody spines present on the trunk and branches. 
The plant is commonly used in folk medicine to treat 
inflammatory disorders, and popularly known as “pau 
jacaré” (alligator stick). Phytochemical studies have be 
performed on the composition of P. gonoacantha, and 
a number of compounds have been identified such as 
triterpenes (friedelin, lupenone, lupeol, cycloartenone, 
cycloartan-25-26-en-3-one, 24-methylene-cycloartano-
ne, and 24-methylenecycloartanol), steroids (sitosterol, 
campesterol, and stigmasterol), saponin (sitosterol-3-O
-β-D-glucopyranoside), flavonoids (apigenin, 5-methyla-
pigenin, 7,4’-dihydroxy-3’,5-dimethoxyflavone, vitexin, 
and isovitexin), asperphenamate and methyl gallate 
(Carvalho et al., 2010). However, no research has been 
investigated on the analgesic and anti-inflammatory 
activity of P. gonoacantha yet.
In this study, we investigated the analgesic and anti
-inflammatory activities of the hydroalcoholic extract of 
P. gonoacantha (EPG) following oral administration in 
experimental animal models. The analgesic activity was 
evaluated by acetic acid-induced writhing response and 
hot plate test. Anti-inflammatory activity was determi-
ned by using carrageenan-induced paw edema model.
2 Materials and methods
2.1. Plant material and extract preparation
Fresh leaves of Piptadenia gonoacantha were collected 
in Viçosa, MG, Brazil. The plant material was identified 
and the voucher specimen (no. 35530) is deposited in the 
herbarium of Federal University of Viçosa.
The leaves of P. gonoacantha were air dried at 40 ◦C 
and the dried material was then powdered using a knife 
mill (Marconi, Brazil). The hydroalcoholic extract was 
prepared according to Carvalho et al. (2011). Briefly, 200g 
of dried powder was submitted to ultrasound-assisted 
extraction in aqueous ethanol (80%) for 1h at 40 °C. The 
extract was filtrated and evaporated to dryness using 
a rotavapor Q344B1 (Quimis, Brazil). The solutions of 
hydroalcoholic extracts of P. gonoacantha leaves (EPG) 
was prepared by dissolving a given quantity of the 
ethanolic extract in a small volume of dimethylsulfoxide 
(DMSO) and made up to the appropriate volume with 
physiological saline.
2.2. Phytochemical group tests
The ethanolic extracts of P gonoacantha were screened 
by using standard procedures of phytochemical group 
tests (Simões et al., 2004). The extracts were screened for 
the presence of alkaloids, anthraquinones, cardiotonic 
heterosides, coumarins, flavonoids, phenolic compounds, 
saponins, tannins, and terpenoids. The reagents were 
first tested by using standard drugs of corresponding 
groups available in market. 
2.3. Brine shrimp lethality assay
In vitro preliminary cytotoxicity assay was performed 
according to the method of Meyer et al. (1982) adapted 
by Carvalho et al. (2009). Briefly, brine shrimp (Artemia 
salina) nauplii were hatched in sterile brine solution 
(prepared using sea salt 38 g/L and adjusted the pH to 
8.5 using 1N NaOH) under constant aeration at 25 ºC 
for 48 hours. After hatching, 10 nauplii were placed in 
each vial and various concentrations of EPG (250, 500, 
1000, 1500, 2000 and 2500 mg/L) were added to each vial 
in a final volume of 5 mL and maintained at 37°C for 
24 hours. The mortality end point of the bioassay was 
determined as the absence of controlled forward motion 
during 30 seconds of observation. Negative and positi-
ve controls were simultaneously performed using the 
same concentrations of the working solvent and K2Cr2O7 
(0.33 mM), respectively. The assays were performed in 
triplicate and calculate LC50 (the concentration of extract 
which caused 50 per cent mortality) based on Litchifield 
& Wilcoxon method (Litchfield and Wilcoxon, 1949).
2.4. Animals
Female albino Wistar rats (190-210 g) were obtained 
from the central animal house of the Federal University 
of Viçosa – UFV. They were kept at standard environ-
mental conditions (12/12-h light/dark cycle) at the animal 
house of the School of Biological and Health Sciences 
– UNIVIÇOSA and were allowed free access to food 
and water. Before each test, the animals were fasted for 
12 h with free access to water. The rats were randomly 
divided into tests and controls groups (n = 6) as will be 
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described further below. 
The experimental protocol used in this study was 
approved (0006/2011-I) by the Ethics Committee of the 
School of Biological and Health Sciences – UNIVIÇOSA, 
and conforms with the Brazilian College for Animal 
Experimentation (COBEA) and with actual Brazilian 
legislation.
2.5. Writhing test
The antinociceptive activity of EPG was performed 
according to the method of Dutra et al. (2006). Acetic acid 
solution 0.6% (0.25 mL/animal) was injected intraperi-
toneally, and the constriction of the abdominal muscles 
together with stretching of the hind limbs was counted 
over a 20 min period starting 5 min after acetic acid in-
jection. EPG (50, 100, and 150 mg/kg, P.O.), indomethacin 
(10 mg/kg, P.O.) as the standard drug (positive control), 
and vehicle (1 mL of 1% DMSO in saline, P.O.) as the 
negative control were administered 30 minutes before 
the acetic acid injection. The results were expressed as 
the mean number of writhing accumulated over 20 min 
experimental evaluation.
2.6. Hot Plate Test
The hot plate test was used to measure response la-
tencies according to the method previously described by 
Eddy and Leimbach (1953). The hot plate was maintained 
at 54 ± 1°C. The time taken (in seconds) to cause a dis-
comfort reaction (licking paws or jumping) was recorded 
as the response latency 30 min after administration of 
EPG (50, 100, and 150 mg/kg, P.O.), indomethacin (10 
mg/kg, P.O.) as positive control, and vehicle (1 mL of 1% 
DMSO in saline, P.O.) as the negative control. A latency 
period of 10 sec was defined as complete analgesia. To 
avoid tissue injury, the experiment was stopped if the 
latency period was exceeded.
2.7. Paw edema tests 
The anti-inflammatory effects of EPG were evaluated 
using the carrageenan-induced paw edema test in rats, 
according to the method of Ceccherelli et al. (1996). 
Briefly, rats were injected subplantarly into the right 
hind paw with 50 µL of carrageenan suspension (1% 
in saline). The left hind paw was injected with 50 µL 
of saline and used as a control. The paw diameters of 
each group were measured prior to and 1, 2, and 3 hours 
after carrageenan administration using a digital caliper 
(Marbeg). EPG (250, 500, and 750 mg/kg, P.O.) was admi-
nistered 30 minutes prior to carrageenan injection. The 
control group received an equivalent volume of water. 
Indomethacin (10 mg/kg, P.O.) was used as the reference 
drug. The percent inhibition of edema was calculated. 
2.8. Statistical Analysis
All data are expressed as Mean ± SEM. The result 
was tested by One-Way ANOVA and Dunnett post test 
(GraphPad Prism 5.0, USA). P < 0.05 was considered 
statistically significant.
3  Results
The hydroalcoholic extracts of P. gonoacantha (EPG) 
submitted to phytochemical screening revealed the pre-
sence of flavonoids, phenolic compounds, and tannins. 
The resulting data are summarized in Table 1.
In vitro cytotoxic activity of EPG using brine shrimp 
lethality assay revealed that these compounds inhibited 
the Artemia salina nauplii in a dose dependent manner 
(fig. 1). The LC50 values of EPG was found to be 1,508 
mg/L, that indicates a low toxicity of the extract.
Oral administration of 0.6% acetic acid produced a 
substantial number of writhes in control rats pretreated 
with vehicle (1 mL of 1% DMSO in saline) (Fig. 2). EPG 
(50, 100, and 150 mg/kg) significantly decreased the num-
ber of acetic acid-induced writhes (Fig. 2). 100 mg/kg of 
EPG showed best results reducing the writhes by 71.8%. 
50 mg/kg and 150 mg/kg of EPG produced 61.3% and 
64.9% reduction in writhes, respectively. These results 
were found to be highly significant compared with the 
control group. However, oral administration of EPG 
(50, 100, and 150 mg/kg) failed to prolong significantly 
the latency time compared with control animals in the 
hot plate test (Fig. 3). Indomethacin (10 mg/kg) the 
positive control used in this study produced inhibition 
of writhing movements, about 43.1% and prolongs the 
latency time significantly (Fig. 3).
TABLE 1. Phytochemical analysis of EPG.
Phytochemical Test EPG 
Alkaloids 
Dragendorff 
Hager 
Mayer 
– 
– 
– 
Anthraquinones Borntrager – 
Cardiotonic 
heterosides 
Baljet 
Kedde 
– 
– 
Coumarins Potassium hydroxide – 
Flavonoids 
Shinoda 
Ferric chloride 
Aluminum chloride 
+ 
+ 
+ 
Phenolic 
compounds 
Folin–Ciocalteu + 
Saponins Honeycomb froth – 
Tannins 
Iron salts 
Gelatin-salt 
+ 
+ 
Terpenoids Liebermann-Burchard – 
 
-: Absent; +: present
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FIGURE 1. Artemia salina (brine shrimp) lethality 
test of EPG. Dilutions of a hydroalcoholic extracts of 
P. gonoacantha, were incubated with A. salina and 
the percentage mortality was monitored after 24 h 
exposure on different concentrations of the extracts.
FIGURE 2. Antinociceptive effects of oral 
administration of EPG (50, 100, and 150 mg/kg) and 
indomethacin (10mg/kg) on acetic acid-induced 
writhing response in rats. Each value represents mean 
± SEM (n = 6). The number of abdominal writhes was 
counted over the time period of 5–25min after acetic 
acid injection. *P < 0.05, **P < 0.01 and ***P < 0.001 
as compared to the control group (one-way ANOVA 
followed by Dunnett’s test).
FIGURE 3. Effect of oral administration of EPG (50, 
100, and 150 mg/kg) and indomethacin (10mg/kg) on 
the pain threshold of mice in the hot plate test. Data 
are mean ± SEM values for response time. *P < 0.05 
compared to the control group (one-way ANOVA 
followed by Dunnett’s test).
FIGURE 4. Effect of oral administration of EPG (50, 
100 and 150 mg/kg) and indomethacin (10mg/kg) on 
carrageenan-induced rat paw edema. The paw edema 
volume was taken at the 3rd hour after carragegenan 
injection. Each column represents the mean ± SEM. 
(n = 6). *P < 0.05 and **P < 0.01 as compared to 
the control group (one-way ANOVA followed by 
Dunnett’s test).
TABLE 2. Effect of the administration of hydroalcoholic extracts of P. gonoacantha (EPG) on carrageenan-
induced edema rat paw.
The results are expressed as Mean ± SEM (n = 6). INDO - indomethacin. *P<0.05, **P<0.01, ANOVA followed by Dunnett’s test.
Groups Dose  Paw volume increase  Inhibition (%) 
 (mg/kg) 1 h 2 h 3 h  1 h 2h 3 h 
Control  1.54 ± 0.37 2.35 ± 0.17 3.25 ± 0.10     
INDO 10 0.75 ± 0.17 1.38 ± 0.27 1.58 ± 0.24**  51.3 41.3 51.4 
EPG 50 0.86 ± 0.13 1.59 ± 0.36 2.13 ± 0.40*  44.1 32.3 34.5 
EPG 100 0.68 ± 0.02* 1.42 ± 0.12 2.03 ± 0.15*  55.8 39.6 37.5 
EPG 150 1.24 ± 0.14 2.32 ± 0.12 2.55 ± 0.26  19.5 1.3 21.5 
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Carrageenan (1%) injected into the subplantar of the 
right hind paws of the rats pretreated with vehicle (1% 
DMSO in saline) caused an acute inflammatory respon-
se. The edema reached its maximum intensity 3h after 
injection after administration of the phlogistic agent. The 
oral administration of EPG at doses of 50, and 100 mg/
kg significantly inhibited paw edema at 3rd h after the 
injection (Fig. 4 and Table 2). EPG at the concentrations 
of 50 and 100 mg/kg had about equal amount of inhibi-
tion as 34.5% and 37.5%, respectively. Indomethacin (10 
mg/kg) profoundly reduced the carrageenan-induced 
edema in the right hind paws of rats, around 51.4% at 
3rd h of measurement (Fig. 4).
4. Discussion
The World Health Organization (WHO) considers a 
toxic substance that has LC50 > 1000 mg/L for brine shrimp 
lethality assay (WHO, 1965; Meyer et al., 1982). Anyway 
the EPG LC50 was 10 times greater than the greatest dose 
used in antinociceptive and anti-inflammatory assays, 
the EPG did not induce lethality or any other signs of 
toxicity at doses up to 250 mg/L. The high LC50 values 
also suggest that EPG were relatively safe and nontoxic 
to the animals.
Two different antinociceptive testing methods were 
employed in the current investigation, with the objective 
of identifying possible peripheral (acetic acid-induced 
writhing test) and central (hot plate test) effects. EPG 
exhibited significant antinociceptive activity against 
chemical stimuli (acetic acid tests), but not against 
thermal stimuli, suggesting that EPG predominantly 
inhibits peripheral, rather than central, pain mechanisms. 
Acetic acid indirectly triggers the release of nociceptive 
endogenous mediators (such as bradykinin, serotonin, 
and prostaglandin) to cause painful sensation (Liao et 
al., 2012). Since EPG also attenuated acetic acid-induced 
writhing, it is probable that the plant species may be 
producing its antinociceptive activity by affecting the 
prostaglandin system.
Carrageenan-induced edema is an experimental ani-
mal model for acute inflammation and it is a biphasic 
response. In the early phase (1–2h) of this assay is mainly 
mediated by histamine, serotonin and an increasing 
synthesis of prostaglandins in the damaged tissue sur-
roundings. The late phase is sustained by prostaglan-
din release (Antonio and Souza Brito, 1998). Our data 
showed that EPG demonstrated antinociceptive activity 
against chemical stimuli and inhibited the formation of 
the carragegenan-induced rat paw edema, these  effects 
might be partially related to inhibition of prostaglandin 
synthesis (Fig. 5). Prostaglandins (PGs) are responsible 
for inflammation features, and cyclooxygenase (COX) 
enzymes catalyze the first steps in their biosynthesis 
(Teather et al., 2002). COX-2 is referred to as the indu-
cible isoform of COX, since levels of COX-2 increase in 
response to several stimulus, including inflammation 
process (Berenguer et al., 2002; Teather et al., 2002).
Substances present in the plant extracts may inter-
fering with the initiation of the inflammatory response 
(Castardo et al., 2008). 
In EPG was identified presence of flavonoids like 
apigenins, vitexin, and isovitexin (Carvalho et al., 2010), 
which have previously demonstrated to possess antinoci-
ceptive and anti-inflammatory activities (Mills and Bone, 
2000; Jeong et al., 2009; Alves et al., 2012). Some flavonoids 
may interfere with inflammatory response by inhibiting 
COX-2 (Havsteen, 2002). Therefore, based on the results 
of this study, we can suggest that the antinociceptive 
and anti-inflammatory effect of EPG may be attributed 
to inhibition of COX-2 and prostaglandin release. 
FIGURE 5. Graphical Abstract of antinociceptive and anti-inflammatory effects of hydroalcoholic extract of 
leaves of Piptadenia gonoacantha (Mart.) Macbr. in experimental animal models
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5. Conclusion
In conclusion, the data obtained show that P. gonoa-
cantha has both antinociceptive and anti-inflammatory 
activities, and that it has been used in folk medicine 
to treat inflammatory disorders, the obtained results 
corroborate the folkloric use this plant. In addition, this 
plant would be a good candidate for further develop-
ment of a new phytotherapeutical medicine. Also, the 
obtained results in this work contribute significantly 
to the pharmacological validation for the safe use of 
P. gonoacantha. However, more studies are needed to 
further elucidate the mechanism of the antinociceptive 
and anti-inflammatory actions of P. gonoacantha.
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